$295.00
+1.70 (+0.580%)
At Close: Jun 03, 2026
Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System
01:01pm, Monday, 19'th May 2025
Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. PORTAGE, Mich.
Baron Opportunity Fund Q1 2025 Top Contributors And Detractors
08:05am, Thursday, 15'th May 2025
xAI Holdings led performance, driven by rapid AI innovation, Grok 3 launch, and the strategic acquisition of X, enhancing data access and integration. Spotify delivered strong results with margin expa
Stryker Corporation (SYK) Bank of America Securities 2025 Global Healthcare Conference (Transcript)
08:23pm, Tuesday, 13'th May 2025
Stryker Corporation (NYSE:SYK ) Bank of America Securities 2025 Global Healthcare Conference May 13, 2025 4:40 PM ET Company Participants Preston Wells - Chief Financial Officer Jason Beach - Vice Pre
Billionaire Terry Smith, "the English Warren Buffett," Has 31% of His Hedge Fund's Portfolio Invested in 3 Exceptional Stocks
04:10am, Saturday, 10'th May 2025
If you read Fundsmith's Owner's Manual, the influence of Warren Buffett on Terry Smith's hedge fund is plainly obvious. Smith references the Oracle of Omaha's wisdom and Berkshire Hathaway's success n
Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold)
05:42pm, Friday, 09'th May 2025
I am downgrading Stryker Corporation to a Hold rating with a fair value of $380 per share, despite strong performance and growth prospects. Stryker's Mako spine and shoulder applications are set to la
Stryker declares an $0.84 per share quarterly dividend
08:00am, Thursday, 08'th May 2025
Portage, Michigan, May 08, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable July 31, 2025, to shareholders
Final Trades: Rockwell Automation, Alerian MLP, Lockheed Martin and Stryker
02:20pm, Monday, 05'th May 2025
The Investment Committee kick off the week with their top picks. Don't miss it!
Stryker (SYK) Reports Q1 Earnings: What Key Metrics Have to Say
07:30pm, Friday, 02'nd May 2025
Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street e
SYK Stock Falls Despite Q1 Earnings & Sales Beat on Lower '25 EPS View
02:25pm, Friday, 02'nd May 2025
SYK's first-quarter results reflect strong segmental performance, along with a rise in operating margin.
Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript
08:28pm, Thursday, 01'st May 2025
Stryker Corporation (NYSE:SYK ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Jason Beach - Vice President, Finance and In
Stryker beats quarterly estimates of string medical device demand
06:33pm, Thursday, 01'st May 2025
Stryker beat Wall Street estimates for quarterly profit on Thursday, fueled by strong demand for its medical and surgical devices.
Stryker (SYK) Surpasses Q1 Earnings and Revenue Estimates
06:20pm, Thursday, 01'st May 2025
Stryker (SYK) came out with quarterly earnings of $2.84 per share, beating the Zacks Consensus Estimate of $2.73 per share. This compares to earnings of $2.50 per share a year ago.
Stryker reports first quarter 2025 operating results
04:05pm, Thursday, 01'st May 2025
Portage, Michigan, May 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2025: First Quarter Results Reported net sales increased 11.9% to $5.9 billio
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
11:55am, Wednesday, 30'th Apr 2025
This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.
Strong Segmental Performance to Drive Stryker's Q1 Earnings?
10:05am, Wednesday, 30'th Apr 2025
SYK's first-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Sign In
Buy SYK